Skip to content

Clinical trials

Phase 1/2 Pancreatic Neoplasms trials in the Netherlands

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Pancreatic Neoplasms Phase: Phase 1/2 Country / region: Netherlands Clear all

15 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20001
20092
20101
20131
20152
20162
20201
20233
20242

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed7
Recruiting3
Unknown status3
Active, not recruiting1
Terminated1

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
Academisch Medisch Centrum - Universiteit van Amsterdam (AMC-UvA)2
Amsterdam UMC, location VUmc2
Eli Lilly and Company1
Erasmus Medical Center1
Gilead Sciences1
Joachim Aerts, MD PhD1
M.R. Meijerink1
Maastricht University Medical Center1
Radboud University Medical Center1
Revolution Medicines, Inc.1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Pancreatic Neoplasms15
Colorectal Neoplasms3
Rectal Neoplasms3
Carcinoma, Non-Small-Cell Lung2
Colonic Neoplasms2
Gastrointestinal Neoplasms2
Neoplasm Metastasis2
Neoplasms2
Ovarian Neoplasms2
Appendiceal Neoplasms1

Trials

Showing 1 to 15 of 15. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.